about
Ischemic stroke and repair: current trends in research and tissue engineering treatmentsThe efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular diseaseAquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodentsFrom basic to clinical neuropharmacology: targetophilia or pharmacodynamics?Role of animal studies in the design of clinical trialsActivation of liver X receptor reduces global ischemic brain injury by reduction of nuclear factor-kappaBNeuroprotective effects of consuming bovine colostrum after focal brain ischemia/reperfusion injury in rat modelPinocembrin alleviates memory impairment in transient global cerebral ischemic rats.Extracellular proteases as targets for drug developmentAdvances in stroke therapyResveratrol alleviates nerve injury after cerebral ischemia and reperfusion in mice by inhibiting inflammation and apoptosisWhat is the use of hypothermia for neuroprotection after out-of-hospital cardiac arrest?The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitroSafety and efficacy evaluation of carnosine, an endogenous neuroprotective agent for ischemic stroke.Neuroprotection and stroke: time for a compromise.Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possiblyNeuroregenerative strategies in the brain: emerging significance of bone morphogenetic protein 7 (BMP7).PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.Hyperthermia exacerbates ischaemic brain injury.Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms.Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review).Small molecule inhibitors in the treatment of cerebral ischemia.The promise of futility trials in neurological diseases.Current and future bioanalytical approaches for stroke assessment.Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.Chemical modification of the multitarget neuroprotective compound fisetin.A novel approach to screening for new neuroprotective compounds for the treatment of stroke.Bone morphogenetic protein-7 ameliorates cerebral ischemia and reperfusion injury via inhibiting oxidative stress and neuronal apoptosis.Monocyte-lymphocyte cross-communication via soluble CD163 directly links innate immune system activation and adaptive immune system suppression following ischemic stroke.Expression Pattern of Peroxisome Proliferator-Activated Receptors in Rat Hippocampus following Cerebral Ischemia and Reperfusion InjuryPotential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.Oxygen glucose deprivation model of cerebral stroke in PC-12 cells: glucose as a limiting factor.Rodent brain imaging with SPECT/CT.Investigating the free radical trapping ability of NXY-059, S-PBN and PBN.The antioxidant effects of Joongpoongtang 05 on brain injury after transient focal cerebral ischemia in rats.Neuroprotection: where to now?Reactive Oxygen Species Formation in the Brain at Different Oxygen Levels: The Role of Hypoxia Inducible Factors
P2860
Q26851602-454CF475-FF70-487D-97D5-C3D669296018Q27015129-9F300161-6B6C-4508-AEA8-8ECA05DA682AQ28536674-EB379660-D565-4A6D-AB33-B7BDBD343B18Q30453956-3CD90300-287A-4051-9753-33D688E901F8Q33609005-1A1FC932-3B3A-48BE-8027-8D15DA68B25BQ33708001-1CEF1CA1-535C-4AAF-B39E-69720A32AB3CQ33955612-2A8B6839-A543-41F3-83E3-DAA0F6AF0102Q34119638-BC59BEEE-33D2-4296-B2DD-1CA0AB2EFE6FQ35116202-4697B3AE-9161-4E44-938A-3C32907869CEQ35632748-855099C7-387B-402B-8D5C-48734EA9B131Q35643484-16032262-E4C0-46A2-9936-E176CCEDFBA9Q35645234-E36F410E-1C81-4AB1-867B-FFE0CD2C046BQ36381508-851F2966-3070-4614-B611-C5A3EB8D2BE8Q36917400-2344AB7F-429D-48CB-950F-D77AD17E340CQ36922560-AC484E26-A344-41BA-8181-9FC8D3DE31AEQ37024492-845F6DCE-28B3-4465-8DB0-D4908DB4C2F5Q37299278-7C3DC2FA-8C15-4070-987A-D6B942E88177Q37362740-72F4A9A7-0573-4E25-99EE-7FDBAEF4151EQ37582010-9BCE7B2E-8FA5-4AD1-A687-FF4113538F91Q37627662-9DFCBEF8-05F8-4946-ABEC-98EC1FF2335EQ37630654-FBB0CCAF-B921-4220-B5CF-AD38AC7F0B1FQ38042627-F18AF498-CD42-43BE-A984-55EAA1FB53CDQ38184644-DF75EC8A-48E0-410E-A2EF-484B63CD17EFQ38380170-2AF47B42-5B90-46D3-8179-4431A33BC46AQ38475374-E4524974-E33E-4FB5-B1A3-28488578FBEEQ38572902-BF2FC338-A5FA-4B48-9886-D194D606F305Q39423915-9FF0E130-4850-41EA-A504-AFBDDE377582Q40086328-C1B418CD-C883-465F-8C5B-0D84C0F3AA28Q41854439-971F34CA-A213-41CE-83DB-32A278774A57Q42374943-6C5E9C05-B752-482F-A847-210DE39C21A9Q42413327-1F75D5DD-E6C8-4DF4-93A7-BF7DE16FB6F7Q43079903-429D9927-B90B-4E04-92C4-33C8A129A765Q43271959-017E7369-A64F-4293-9E10-7519B568C4AFQ46063613-FA8FEB8E-E320-4907-B335-BC5274015596Q50667701-6D2B9012-E8D4-425B-B1AA-96FBC6CF5321Q53443881-07CC7AB5-BC6D-4AF5-A135-D304A7F2E0BDQ57564070-FBE2EB98-D630-48F9-8552-59ADA04BBE2DQ58575600-1A01C9E3-77A6-46E8-9598-DAFF986C2DA6
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Therapeutic strategies for the treatment of stroke.
@ast
Therapeutic strategies for the treatment of stroke.
@en
type
label
Therapeutic strategies for the treatment of stroke.
@ast
Therapeutic strategies for the treatment of stroke.
@en
prefLabel
Therapeutic strategies for the treatment of stroke.
@ast
Therapeutic strategies for the treatment of stroke.
@en
P1433
P1476
Therapeutic strategies for the treatment of stroke.
@en
P2093
A Richard Green
Ashfaq Shuaib
P304
P356
10.1016/J.DRUDIS.2006.06.001
P577
2006-08-01T00:00:00Z